NasdaqCM - Delayed Quote • USD
Compass Therapeutics, Inc. (CMPX)
At close: April 24 at 4:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 18.49M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SCHUETZ THOMAS J Officer and Director | Stock Award(Grant) at price 1.93 per share. | Direct | 1,230,375 | Jan 9, 2024 |
| BISKER-LEIB VERED Chief Executive Officer | Stock Award(Grant) at price 1.93 per share. | Direct | 3,383,531 | Jan 9, 2024 |
| SCHUETZ THOMAS J Chief Executive Officer | Purchase at price 3.37 per share. | Direct | 33,700 | Mar 10, 2023 |
| SCHUETZ THOMAS J Chief Executive Officer | Purchase at price 3.98 per share. | Direct | 79,600 | Feb 27, 2023 |
| SCHUETZ THOMAS J Chief Executive Officer | Purchase at price 3.86 per share. | Direct | 77,200 | Feb 15, 2023 |
| SCHUETZ THOMAS J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 8, 2023 |
| BISKER-LEIB VERED Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 8, 2023 |
| SCHUETZ THOMAS J Chief Executive Officer | Purchase at price 4.05 per share. | Direct | 81,000 | Jan 31, 2023 |
| SCHUETZ THOMAS J Chief Executive Officer | Purchase at price 4.19 per share. | Direct | 83,800 | Jan 24, 2023 |
| BISKER-LEIB VERED Chief Operating Officer | Sale at price 4.19 - 4.36 per share. | Direct | 103,708 | Nov 25, 2022 |
| BISKER-LEIB VERED Chief Operating Officer | Sale at price 4.34 - 4.40 per share. | Direct | 96,986 | Nov 21, 2022 |
| ORBIMED ADVISORS, L.L.C. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 4.25 per share. | Indirect | 1,708,500 | Nov 8, 2022 |
| GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 4.25 per share. | Indirect | 1,708,500 | Nov 8, 2022 |
| SCHUETZ THOMAS J Chief Executive Officer | Purchase at price 2.32 per share. | Direct | 23,200 | Sep 28, 2022 |
| SCHUETZ THOMAS J Chief Executive Officer | Purchase at price 2.27 per share. | Direct | 34,050 | Sep 26, 2022 |
| SCHUETZ THOMAS J Chief Executive Officer | Purchase at price 3.03 per share. | Direct | 45,450 | Sep 7, 2022 |
| SCHUETZ THOMAS J Chief Executive Officer | Purchase at price 2.83 per share. | Direct | 42,450 | Sep 1, 2022 |
| SCHUETZ THOMAS J Chief Executive Officer | Purchase at price 3.05 per share. | Direct | 45,750 | Aug 17, 2022 |
| SCHUETZ THOMAS J Chief Executive Officer | Purchase at price 2.64 per share. | Direct | 39,600 | Aug 10, 2022 |
| SCHUETZ THOMAS J Chief Executive Officer | Purchase at price 2.58 per share. | Direct | 38,700 | Aug 1, 2022 |
| SCHUETZ THOMAS J Chief Executive Officer | Purchase at price 2.80 per share. | Direct | 56,000 | Jun 21, 2022 |
| SCHUETZ THOMAS J Chief Executive Officer | Purchase at price 2.34 per share. | Direct | 46,800 | Jun 16, 2022 |
| SCHUETZ THOMAS J Chief Executive Officer | Purchase at price 2.29 per share. | Direct | 68,700 | Jun 13, 2022 |
| SCHUETZ THOMAS J Chief Executive Officer | Purchase at price 2.83 per share. | Direct | 84,900 | Jun 6, 2022 |
| SCHUETZ THOMAS J Chief Executive Officer | Purchase at price 3.03 per share. | Direct | 60,600 | Jun 1, 2022 |
| SCHUETZ THOMAS J Chief Executive Officer | Purchase at price 3.04 per share. | Direct | 60,800 | May 26, 2022 |
| SCHUETZ THOMAS J Chief Executive Officer | Purchase at price 2.72 per share. | Direct | 49,926 | May 23, 2022 |
| SCHUETZ THOMAS J Chief Executive Officer | Purchase at price 2.47 per share. | Direct | 49,931 | May 17, 2022 |
| ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.79 - 2.49 per share. | Indirect | 420,482 | May 13, 2022 |
| GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.79 - 2.49 per share. | Indirect | 420,482 | May 13, 2022 |
| ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.56 - 1.63 per share. | Indirect | 197,252 | May 10, 2022 |
| GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.56 - 1.63 per share. | Indirect | 197,252 | May 10, 2022 |
| SCHUETZ THOMAS J Chief Executive Officer | Purchase at price 1.80 per share. | Direct | 50,105 | May 10, 2022 |
| SCHUETZ THOMAS J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 16, 2021 |
| BISKER-LEIB VERED Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 16, 2021 |
| ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.50 per share. | Indirect | 18,750,000 | Nov 4, 2021 |
| GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.50 per share. | Indirect | 18,750,000 | Nov 4, 2021 |
Related Tickers
VOR Vor Biopharma Inc.
1.7400
-7.45%
IKNA Ikena Oncology, Inc.
1.2900
-4.44%
IVA Inventiva S.A.
3.2400
-2.70%
KZR Kezar Life Sciences, Inc.
0.8014
-2.98%
CALC CalciMedica, Inc.
5.49
+19.87%
TSBX Turnstone Biologics Corp.
3.0700
+0.33%
BOLT Bolt Biotherapeutics, Inc.
1.2002
+8.13%
ANTX AN2 Therapeutics, Inc.
2.4000
+1.27%
THRD Third Harmonic Bio, Inc.
11.33
+2.53%
ALGS Aligos Therapeutics, Inc.
0.8290
+0.66%